Clinical Trial Update: Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso) [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial evaluating atezolizumab versus placebo as adjuvant therapy for malignant pleural mesothelioma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica | Conditions: Mesotheliomas Pleural | Phase 3 | Status: RECRUITING